Edap Tms’ (EDAP) Buy Rating Reiterated at HC Wainwright

HC Wainwright reiterated their buy rating on shares of Edap Tms (NASDAQ:EDAP) in a research report released on Friday morning,Benzinga reports. The firm currently has a $19.00 target price on the medical equipment provider’s stock. HC Wainwright also issued estimates for Edap Tms’ FY2029 earnings at $0.40 EPS.

Separately, StockNews.com started coverage on shares of Edap Tms in a report on Friday. They set a “hold” rating for the company.

Edap Tms Trading Down 3.2 %

Shares of EDAP stock opened at $2.15 on Friday. The company has a quick ratio of 1.46, a current ratio of 2.18 and a debt-to-equity ratio of 0.08. The firm has a market cap of $79.77 million, a P/E ratio of -3.31 and a beta of 0.37. The company has a 50 day moving average of $2.42 and a 200-day moving average of $2.50. Edap Tms has a 12-month low of $1.96 and a 12-month high of $8.50.

Edap Tms (NASDAQ:EDAP) last posted its earnings results on Thursday, March 27th. The medical equipment provider reported ($0.05) earnings per share for the quarter, topping the consensus estimate of ($0.11) by $0.06. The firm had revenue of $22.69 million during the quarter, compared to the consensus estimate of $20.83 million. Edap Tms had a negative net margin of 34.92% and a negative return on equity of 44.21%. Sell-side analysts anticipate that Edap Tms will post -0.6 earnings per share for the current year.

Institutional Trading of Edap Tms

Large investors have recently added to or reduced their stakes in the stock. Parkman Healthcare Partners LLC purchased a new stake in shares of Edap Tms in the third quarter worth $395,000. Jane Street Group LLC grew its holdings in shares of Edap Tms by 174.7% during the fourth quarter. Jane Street Group LLC now owns 31,361 shares of the medical equipment provider’s stock valued at $69,000 after buying an additional 73,361 shares during the last quarter. Schonfeld Strategic Advisors LLC increased its position in shares of Edap Tms by 48.5% during the fourth quarter. Schonfeld Strategic Advisors LLC now owns 160,800 shares of the medical equipment provider’s stock valued at $355,000 after acquiring an additional 52,500 shares in the last quarter. Millennium Management LLC increased its position in shares of Edap Tms by 218.5% during the fourth quarter. Millennium Management LLC now owns 48,915 shares of the medical equipment provider’s stock valued at $108,000 after acquiring an additional 33,558 shares in the last quarter. Finally, BNP Paribas Financial Markets raised its holdings in Edap Tms by 111.5% in the 4th quarter. BNP Paribas Financial Markets now owns 48,650 shares of the medical equipment provider’s stock worth $108,000 after acquiring an additional 25,650 shares during the last quarter. Institutional investors own 62.74% of the company’s stock.

About Edap Tms

EDAP TMS SA is a holding company, which, through its subsidiary, engages in the development, production, and marketing of minimally invasive medical devices for urological diseases. It operates through the High Intensity Focused Ultrasound (HIFU) and Urology Devices and Services (UDS) segments. The HIFU segment develops, manufactures, and markets devices for the minimally invasive ablation of certain types of localized tumors using HIFU technology.